Act 221 Success Stories: Cellular Bioengineering

As published in 2009 April 8, Midweek.

Recently, Hank Wuh's company, Cellular Bioengineering Inc., launched its latest product--a gel capable of cleaning up everything fro ma radioactive nuclear spill to ground-in dirt. Paint it on: peel it off the next day. Pretty much as simple as that.

And the worldwide market? Oh, about $200 million.

Already another of the company's phenomenal products--an artificial cornea--is in human clinical trials. It has the potential to return sight to 10 million people around the world whose blindness is caused by corneal disease.

Cellular Bioengineering has grown quickly and supported local hires. Wuh's own Hawaii roots and his schooling--partly at the University of Hawaii, along with Johns Hopkins University, Harvard University and Stanford University--make it important to him to offer opportunities to young people from the Islands.

Intellectual property--in other words, new inventions--is the core of Wuh's company, and in many ways the core of Hawaii's ability to develop an economic sector around high technology.

That core has been supported by Act 221, which has been key to jump-starting research and intellectual property development in the Islands.

With 25 patents in his portfolio, Wuh is already impacting global markets, not just the Hawaii market. The inventions and products his company controls have the potential for upward growth nearly everywhere in the world with the possibility of billions of dollars of business. And all of it is the result of good ideas given good support.

To read full article, click on picture:

No comments:

Post a Comment